Providing normal reference values and the means to interpret such values in practice is an urgent issue requiring consensus. Five basic approaches to defining normalcy for 24 h blood pressures (BP) are considered: 1) the relationship of ambulatory blood pressure (ABP) to morbidity and mortality, 2) the relationship of ABP to end-organ involvement, 3) ABP levels in normal populations, 4) the relationship of ABP to clinic BP, and 5) the relationship of 24 h indices to risk. Although there now is considerable evidence demonstrating that ambulatory measurement correlates more strongly with endsrgan damage, the first two approaches are scientifically the best. It will be some time before levels of normalcy can be derived. There is a large volume of data on population samples permitting derivation of normalcy for clinical practice. Rounded upper limits of normal can be calculated as 140190 mm Hg for 24 h ambulatory pressure, 150190 mm Hg for daytime pressure, and 13W80 mm Hg for nighttime pressure. There are, however, considerable differences for age and gender which need to be taken into consideration. Am J Hypertens
T he importance of establishing normal reference values for blood pressure (BP) levels throughout the 24 h period is of paramount importance if the technique of 24 h ambulatory monitoring is to become established in clinical practice. The most fundamental need of the technique is the establishment of normal reference values. Abnormality cannot be defined without first having established normalcy.
It is evident in Ewope that the technique of 24 h ambulatory measurement is rapidly moving away from the research arena, to which it had been confined foi t h e past 15 years. Pharmaceutical companies in particular are providing ambulatory systems for use in general practice. There is little point in lamenting the inevitability of this development by claiming it to be premature; market forces often dictate the pace of pro-sary to ensure that the technique is used in practice to enhance patient management, and not abused for fiscal advantage. Just as important, we want to ensure that the large amount of data provided by 24 h BP measurement is not misinterpreted because of unfamiliarity with a new methodology.
The need, therefore, for providing normal reference values and the means to interpret such values in practice is an urgent issue requiring consensus. It must be recogruzed that our present state of knowledge may not permit us to provide the reference values to fulfill the precise dictates that scientific methodology requires. It is important for us to use the knowledge we possess (and this is considerable) to establish guidelines for normalcy in clinical practice, recognizing that we may have to adjust these figures slightly as information from longitudinal studies accumulates. We cannot, however, retreat to a position which was once afforded to us when ambulatory measurement was confined solely to research, by opting to tread &en-tiiic waters until the information necessary to make a d a t i v e statement on normalcy becomes available. Research has shown us the important contribution that ambulatory measurement may make to managing hypertensive patienk. The exigencies of developments in ambulatory measurement, primarily the techno-,logical advances in equipment design and research, have rnadea working definition of normal 24 h BPS mandatory.
REVIEW OF AVAILABLE METHODS
The following are five basic approaches to defining normalcy for 24 h BPS that can be considered.
Relationship of ABP to Morbidity and Mortality First, we can relate BP to risk of heart attack, stroke, and death in longitudinal studies. The classical epidemiological approach, used in studies such as the Framinghaml and Multiple Risk Factor Intervention Trial2 studies relating risk to the level of clinic BP, is the ideal one to adopt for ABP. There has been, however, only one such study performed to date. This study was first reported by Dr. Maurice Sokolow's group in 196e3 and subsequently in the intervening years.' This study showed that the relationship between risk and BP is steeper for ABP than for clinic pressure. The results of the study were consistent with the prediction that h e BP would be distinct from dinic BP?
The Office Versus Ambulatory (OVA) trial in Europe is attempting longitudinally to relate the outcome of managing BP on the basis of clinic BP v ABPP The assumption, which awaits confinnation, is that hypertedve s u m managed on the basis of ABPs will have at least as good an outcome as those managed on clinic BP. In addition, subjects may have the advantage of needing less antihypertensive medication, and therefore, may enjoy a better quality of life.
In the Syst-Eur trial,' another multicenter longitudinal study examining antih-ve medication in isolated systolic hypertension, a side project on ABP measurement should provide information on the relationship between 24 h ambulatory measurement and the risk in elderly subjects. There is evidence that patients diagnosed as having isolated systolic hypertension by conventional measurement may not experience the phenomenon when BP is measured over the 24 h period? It is hoped that the implications of this observation will be demonstrated in the Syst-Eur trial.
The approach of relating 24 h ABP to outcome is the most ideal one from a scientific viewpoint. This should enable us to relate actual levels of 24 h BP and variations of the pattern of 24 h pressure, such as blunting of the normal nocturnal p a t t e d to the ultimate cardiovascular consequences of hypertension. The major problem with longitudinal studies is that they take time, usually decades, before pmvid- ing answers. Moreover, theinterpretation of resulk is not always as straightforward as it might seem to be; study design, the effects of other risk factom, and management strategies often prove to be confounding factors.
Relationship of ABP to End-Organ Involvement Another approach in relating 24 h ABP to risk is to substitute the m g a t e end-points of end-organ involve ment for the classical end-points of death and morbidity. n\is technique would establish an association with risk in a shorter period of time.
This approach has been followed in a number o' studies in which the relatiortship of ABP to end-orp involvement as determined in the h-10 kidney,a blood vesseIs,m and brain1' has been shown to be m perior to climc blood pressure. Indeed, with the in aeasing development of techniques for assessing end. organ involvement in hypertension, it can only be a matter of time before the evidence becomes irrefutable However, two important issues need to be clarified. First, one can ask if it is acceptable to substitute sur rogate end-points for the more substantial end-points of morbid events and death In respomk, we mi@ apply the scheme of reasoning outlined in Figure 2 . Clinic BP depicted on the left predicts end-organ involvement in addition to morbidity and death. Therefore, associating end-organ involvement with morbidity and death may be seen as a stepping stone to the ultimate cardiovascular insults of stroke, heart attack and death. If we accept that ABP is a better predictor of end-organ involvement (shown on the right) than clinic BP, it is difficult to escape the conclusion that ABP also must provide us with a sensitive means of predicting outcome in terms of morbidity and death, DBP (mm Hg) Mean f SD 7 7 f 7 8 0 f 6 8329 84f9 8 1 f 8 7456 7 5 f 7 7 6 f 9 7 8 f 9 7 5 f 7 7 8 f 7 ~e d i a n 77 DBP (mm Hg) ~6 a . n f SD 5 9 f 6 6 2 f 6 66f10 68f9 6 3 f 8 5 7 f 6 5 8 f 7 6 1 f 8 6 3 f 7 5 8 f 7 6 1 f 8 Mean f SD 7 l f 5 7 4 f 5 7 7 i 8 79f9 7 5 f 7 68f5 6 9 f 6 7 1 f 8 7 3 f 8 6 9 f 6 7 2 f 7 this study is that the relationship belwcwn ambulatory 10.
and office measurements is derived f r o n~ 522 subjects comprised of normotensives, borderline, mild, moderate, and severe hypertensives. Other weaknesses are that the hypertensive subjects greatly outnumber the ll. normotensive subjects, the hypertensive subjects are older than the normotensive subjects, and the ambulatory measurements were performed with three ambulatory systems, at least one of which had not met the current criteria for accuracy.2s The conclusion that the 12. disparity between office and ABP was unrelated to age and gender would need to be examined more closely.
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